SCHEMBL23269409

SCHEMBL23269409

Cc1cc(C(F)(F)F)nc(C)c1CO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
KDM4E B2RXH2 4/20 0.33
LMNA P02545 2/20 0.33
TKT P29401 1/20 0.33
KMT2A Q03164 5/20 0.33
MEN1 O00255 3/20 0.33
HSD17B10 Q99714 2/20 0.33
GAA P10253 2/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
CRHBP P24387 1/20 0.32
CYP2C19 P33261 1/20 0.32
CRHR2 Q13324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23269422 0.87 HSP90AA1 (0.40) HSP90AA1HSP90AB1KDM4ELMNAKMT2A
SCHEMBL29464842 0.82 HSP90AA1 (0.37) HSP90AA1HSP90AB1KDM4ELMNATKT
SCHEMBL23269465 0.82 HSP90AA1 (0.37) HSP90AA1HSP90AB1KDM4ELMNATKT
SCHEMBL29076623 0.75 ADORA2A (0.33) HSP90AA1HSP90AB1KDM4EKMT2AMEN1
SCHEMBL11985857 0.74 HSP90AA1 (0.45) HSP90AA1HSP90AB1KDM4ELMNAKMT2A
SCHEMBL18018164 0.72 HSP90AA1 (0.44) HSP90AA1HSP90AB1KDM4ELMNAKMT2A
SCHEMBL14967196 0.71 HSP90AA1 (0.41) HSP90AA1HSP90AB1KDM4ELMNATKT
SCHEMBL21603492 0.71 HSP90AA1 (0.52) HSP90AA1HSP90AB1KDM4ELMNAKMT2A
SCHEMBL25880579 0.71 KLKB1 (0.38) KDM4ELMNAKMT2AHSD17B10CYP3A4
SCHEMBL31214472 0.70 HSP90AA1 (0.35) HSP90AA1HSP90AB1KDM4ELMNATKT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000847-A1 COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION DRAIG THERAPEUTICS LTD (GB) 2023-01-05 US disclosed
US-11298345-B2 Compounds that modulates AMPA receptor function UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2022-04-12 US disclosed
US-20210113539-A1 COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION DRAIG THERAPEUTICS LTD (GB) 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230000847-A1 COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION GRIN1, GRM1, GRIN2A HSP90AA1 4014/4885HSP90AB1 3893/4885KDM4E 3845/4885
US-20210113539-A1 COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION GRIN1, GRM1, GRIN2A HSP90AA1 4014/4885HSP90AB1 3893/4885KDM4E 3845/4885
US-11298345-B2 Compounds that modulates AMPA receptor function GRIN1, GRM1, GRIN2A HSP90AA1 4014/4885HSP90AB1 3893/4885KDM4E 3845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.